No profile data available.
C-mer Medical Holdings Limited (3309.HK) is a healthcare company in the focused walk-in medical services industry, based in Central, Hong Kong, with about 2,317 full-time employees.
It reported revenue of 1.95 billion HKD for fiscal year 2025, up 1.8% from fiscal year 2024, and net income of 100.37 million HKD. Its largest business segment, HK Medical Business, brought in 49% of segment revenue in fiscal year 2025; Mainland China was the largest region with 51%. Its market capitalization was 894.32 million HKD as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
C-MER Medical Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. It operates through five segments: HK Medical Business, Mainland China Ophthalmic Business, Mainland China Dental Business, and Mainland China Other Business.
C-mer Medical Holdings reported 1.95 billion HKD in revenue for fiscal year 2025, up 1.8% from 1.91 billion HKD in fiscal year 2024.
HK Medical Business, with 948.73 million HKD or 49% of segment revenue in fiscal year 2025. Next: Mainland China Ophthalmic Business (27%) and Mainland China Dental Business (24%).
Mainland China: 51% of revenue by region in fiscal year 2025, followed by Hong Kong (49%).
894.32 million HKD as of October 9, 2026.
Listed companies of a similar size in the same industry (focused walk-in medical services) include Jinxin Fertility Group Limited (1951.HK), Arrail Group Limited (6639.HK), Euroeyes (1846.HK), Meihao Medical Group Co., Ltd (1947.HK).